Glucophage Immediate Release (GIR) China Bioequivalence Study
NCT03393208
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Test GIR
DRUG:
Reference GIR
Sponsor
Merck KGaA, Darmstadt, Germany